LIPS Trial
Cross-source consensus on LIPS Trial from 1 sources and 4 claims.
1 sources · 4 claims
Other
Other
Highlighted claims
- The LIPS trial is a pragmatic, multicentre, randomised, placebo-controlled superiority trial in Swiss acute-care hospitals. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- The trial was prospectively registered on ClinicalTrials.gov as NCT06958835. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- The trial uses blinding of participants, treating physicians, and outcome assessors to reduce bias. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- The trial is embedded in routine clinical care, with most outcomes collected from routine medical records. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial